In the meantime, we are working to
develop pharmacogenomic tests that can help to optimize the benefit to patients of currently available treatments.»
Not exact matches
To address this concern, Molecular Pathology and Pharmacy are collaborating to
develop an in - house
pharmacogenomics testing process to provide an additional clinical tool to strengthen the ability to provide quality patient care.
deCODE plans to use its
pharmacogenomic work to
develop and market a
test that can be used to target the prescription of glucocorticoids to those patients for whom these compounds provide the most effective relief with the least possible side - effects.